A Randomized, Double-Blind, Controlled Phase I Trial to Evaluate the Safety, Tolerability, and Immunogenicity of DCB07010 Adjuvant Given Intranasally at Ascending Dose Levels and Co-Administered with Trivalent Inactivated Influenza Virus Antigen (I)
Project title
一項隨機、雙盲、對照性第一期臨床試驗，評估經鼻腔投予DCB07010佐劑在劑量遞增下與三價流感病毒抗原並用的安全性、耐受性與免疫生成性( I )
